nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—ADRB2—Timolol—migraine	0.103	0.138	CbGbCtD
Arformoterol—ADRB1—Timolol—migraine	0.101	0.136	CbGbCtD
Arformoterol—ADRB2—Propranolol—migraine	0.0918	0.123	CbGbCtD
Arformoterol—ADRB1—Propranolol—migraine	0.0905	0.121	CbGbCtD
Arformoterol—CYP2A6—Valproic Acid—migraine	0.0577	0.0775	CbGbCtD
Arformoterol—CYP2C19—Timolol—migraine	0.034	0.0456	CbGbCtD
Arformoterol—CYP2C19—Propranolol—migraine	0.0303	0.0407	CbGbCtD
Arformoterol—CYP2C19—Amitriptyline—migraine	0.0262	0.0352	CbGbCtD
Arformoterol—CYP2D6—Timolol—migraine	0.0258	0.0347	CbGbCtD
Arformoterol—CYP2C19—Valproic Acid—migraine	0.0239	0.0321	CbGbCtD
Arformoterol—CYP2D6—Propranolol—migraine	0.023	0.0309	CbGbCtD
Arformoterol—CYP2C9—Amitriptyline—migraine	0.0218	0.0292	CbGbCtD
Arformoterol—CYP2C19—Topiramate—migraine	0.0216	0.0289	CbGbCtD
Arformoterol—CYP2C19—Verapamil—migraine	0.0208	0.0279	CbGbCtD
Arformoterol—CYP2D6—Amitriptyline—migraine	0.0199	0.0267	CbGbCtD
Arformoterol—CYP2C9—Valproic Acid—migraine	0.0199	0.0267	CbGbCtD
Arformoterol—CYP2C9—Verapamil—migraine	0.0173	0.0232	CbGbCtD
Arformoterol—CYP2D6—Verapamil—migraine	0.0158	0.0212	CbGbCtD
Arformoterol—ADRB1—Endothelin Pathways—RAMP1—migraine	0.00196	0.0388	CbGpPWpGaD
Arformoterol—ADRB1—Endothelin Pathways—CALCRL—migraine	0.00196	0.0388	CbGpPWpGaD
Arformoterol—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.00142	0.0282	CbGpPWpGaD
Arformoterol—ADRB2—Monoamine GPCRs—HTR1D—migraine	0.00139	0.0276	CbGpPWpGaD
Arformoterol—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.00132	0.0262	CbGpPWpGaD
Arformoterol—ADRB2—Monoamine GPCRs—HTR2B—migraine	0.00129	0.0256	CbGpPWpGaD
Arformoterol—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.00119	0.0237	CbGpPWpGaD
Arformoterol—ADRB2—Amine ligand-binding receptors—HTR1D—migraine	0.00117	0.0232	CbGpPWpGaD
Arformoterol—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.00111	0.022	CbGpPWpGaD
Arformoterol—ADRB2—Amine ligand-binding receptors—HTR2B—migraine	0.00109	0.0215	CbGpPWpGaD
Arformoterol—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000861	0.0171	CbGpPWpGaD
Arformoterol—ADRB2—Monoamine GPCRs—HTR1B—migraine	0.000842	0.0167	CbGpPWpGaD
Arformoterol—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000829	0.0164	CbGpPWpGaD
Arformoterol—ADRB2—Monoamine GPCRs—HTR1A—migraine	0.000811	0.0161	CbGpPWpGaD
Arformoterol—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.000801	0.0159	CbGpPWpGaD
Arformoterol—ADRB2—Monoamine GPCRs—HTR2C—migraine	0.000783	0.0155	CbGpPWpGaD
Arformoterol—ADRB1—Endothelin Pathways—EDNRA—migraine	0.000779	0.0154	CbGpPWpGaD
Arformoterol—ADRB1—Endothelin Pathways—CALCA—migraine	0.00075	0.0149	CbGpPWpGaD
Arformoterol—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.000724	0.0144	CbGpPWpGaD
Arformoterol—ADRB2—Amine ligand-binding receptors—HTR1B—migraine	0.000708	0.014	CbGpPWpGaD
Arformoterol—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000701	0.0139	CbGpPWpGaD
Arformoterol—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.000697	0.0138	CbGpPWpGaD
Arformoterol—ADRB2—Monoamine GPCRs—HTR7—migraine	0.000686	0.0136	CbGpPWpGaD
Arformoterol—ADRB2—Amine ligand-binding receptors—HTR1A—migraine	0.000682	0.0135	CbGpPWpGaD
Arformoterol—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000678	0.0134	CbGpPWpGaD
Arformoterol—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000678	0.0134	CbGpPWpGaD
Arformoterol—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.000673	0.0133	CbGpPWpGaD
Arformoterol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.000664	0.0132	CbGpPWpGaD
Arformoterol—ADRB2—G alpha (s) signalling events—RAMP1—migraine	0.000664	0.0132	CbGpPWpGaD
Arformoterol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000658	0.0131	CbGpPWpGaD
Arformoterol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.000612	0.0121	CbGpPWpGaD
Arformoterol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.000589	0.0117	CbGpPWpGaD
Arformoterol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.000577	0.0114	CbGpPWpGaD
Arformoterol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000491	0.00974	CbGpPWpGaD
Arformoterol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.00048	0.00952	CbGpPWpGaD
Arformoterol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000444	0.0088	CbGpPWpGaD
Arformoterol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000434	0.00861	CbGpPWpGaD
Arformoterol—CYP2A6—Fluoropyrimidine Activity—MTHFR—migraine	0.000428	0.00849	CbGpPWpGaD
Arformoterol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000413	0.00818	CbGpPWpGaD
Arformoterol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.000404	0.00801	CbGpPWpGaD
Arformoterol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000338	0.00671	CbGpPWpGaD
Arformoterol—ADRB2—GPCRs, Other—HTR7—migraine	0.000305	0.00604	CbGpPWpGaD
Arformoterol—ADRB1—G alpha (s) signalling events—NPS—migraine	0.000283	0.00561	CbGpPWpGaD
Arformoterol—ADRB2—G alpha (s) signalling events—NPS—migraine	0.000277	0.00549	CbGpPWpGaD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000274	0.00544	CbGpPWpGaD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000268	0.00532	CbGpPWpGaD
Arformoterol—ADRB1—G alpha (s) signalling events—CALCA—migraine	0.00026	0.00515	CbGpPWpGaD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000255	0.00506	CbGpPWpGaD
Arformoterol—Back pain—Valproic Acid—migraine	0.000254	0.00124	CcSEcCtD
Arformoterol—ADRB2—G alpha (s) signalling events—CALCA—migraine	0.000254	0.00504	CbGpPWpGaD
Arformoterol—Headache—Amitriptyline—migraine	0.000253	0.00124	CcSEcCtD
Arformoterol—Bronchitis—Topiramate—migraine	0.000253	0.00124	CcSEcCtD
Arformoterol—Muscle spasms—Valproic Acid—migraine	0.000253	0.00124	CcSEcCtD
Arformoterol—Rhinitis—Gabapentin—migraine	0.000251	0.00123	CcSEcCtD
Arformoterol—Cardiac disorder—Timolol—migraine	0.00025	0.00122	CcSEcCtD
Arformoterol—Feeling abnormal—Verapamil—migraine	0.000249	0.00122	CcSEcCtD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000249	0.00495	CbGpPWpGaD
Arformoterol—Pharyngitis—Gabapentin—migraine	0.000249	0.00121	CcSEcCtD
Arformoterol—Urinary tract disorder—Gabapentin—migraine	0.000247	0.00121	CcSEcCtD
Arformoterol—Oedema peripheral—Gabapentin—migraine	0.000247	0.00121	CcSEcCtD
Arformoterol—Tremor—Valproic Acid—migraine	0.000246	0.0012	CcSEcCtD
Arformoterol—ADRB1—GPCR ligand binding—CALCRL—migraine	0.000246	0.00488	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—RAMP1—migraine	0.000246	0.00488	CbGpPWpGaD
Arformoterol—Connective tissue disorder—Gabapentin—migraine	0.000246	0.0012	CcSEcCtD
Arformoterol—Urethral disorder—Gabapentin—migraine	0.000246	0.0012	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Topiramate—migraine	0.000245	0.0012	CcSEcCtD
Arformoterol—Ill-defined disorder—Valproic Acid—migraine	0.000244	0.00119	CcSEcCtD
Arformoterol—ADRB1—G alpha (s) signalling events—HTR7—migraine	0.000243	0.00482	CbGpPWpGaD
Arformoterol—Immune system disorder—Timolol—migraine	0.000243	0.00119	CcSEcCtD
Arformoterol—Hypersensitivity—Propranolol—migraine	0.000242	0.00118	CcSEcCtD
Arformoterol—Mediastinal disorder—Timolol—migraine	0.000242	0.00118	CcSEcCtD
Arformoterol—Agitation—Valproic Acid—migraine	0.000242	0.00118	CcSEcCtD
Arformoterol—Visual impairment—Gabapentin—migraine	0.000241	0.00118	CcSEcCtD
Arformoterol—ADRB2—GPCR ligand binding—RAMP1—migraine	0.000241	0.00478	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—CALCRL—migraine	0.000241	0.00478	CbGpPWpGaD
Arformoterol—Urticaria—Verapamil—migraine	0.000241	0.00118	CcSEcCtD
Arformoterol—Angioedema—Valproic Acid—migraine	0.00024	0.00117	CcSEcCtD
Arformoterol—Arrhythmia—Timolol—migraine	0.00024	0.00117	CcSEcCtD
Arformoterol—Nausea—Amitriptyline—migraine	0.00024	0.00117	CcSEcCtD
Arformoterol—ADRB2—G alpha (s) signalling events—HTR7—migraine	0.000238	0.00472	CbGpPWpGaD
Arformoterol—Hyperglycaemia—Topiramate—migraine	0.000237	0.00116	CcSEcCtD
Arformoterol—Malaise—Valproic Acid—migraine	0.000237	0.00116	CcSEcCtD
Arformoterol—Asthenia—Propranolol—migraine	0.000236	0.00115	CcSEcCtD
Arformoterol—Mental disorder—Timolol—migraine	0.000236	0.00115	CcSEcCtD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000235	0.00466	CbGpPWpGaD
Arformoterol—Malnutrition—Timolol—migraine	0.000234	0.00114	CcSEcCtD
Arformoterol—Cardiac disorder—Gabapentin—migraine	0.000232	0.00114	CcSEcCtD
Arformoterol—Palpitations—Valproic Acid—migraine	0.000232	0.00114	CcSEcCtD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00023	0.00456	CbGpPWpGaD
Arformoterol—Tension—Timolol—migraine	0.00023	0.00112	CcSEcCtD
Arformoterol—Cough—Valproic Acid—migraine	0.00023	0.00112	CcSEcCtD
Arformoterol—Dysgeusia—Timolol—migraine	0.000229	0.00112	CcSEcCtD
Arformoterol—Conjunctivitis—Topiramate—migraine	0.000228	0.00112	CcSEcCtD
Arformoterol—Urinary tract infection—Topiramate—migraine	0.000228	0.00112	CcSEcCtD
Arformoterol—Nervousness—Timolol—migraine	0.000227	0.00111	CcSEcCtD
Arformoterol—Hypertension—Valproic Acid—migraine	0.000227	0.00111	CcSEcCtD
Arformoterol—Immune system disorder—Gabapentin—migraine	0.000226	0.00111	CcSEcCtD
Arformoterol—Mediastinal disorder—Gabapentin—migraine	0.000226	0.0011	CcSEcCtD
Arformoterol—Diarrhoea—Propranolol—migraine	0.000225	0.0011	CcSEcCtD
Arformoterol—Myalgia—Valproic Acid—migraine	0.000224	0.00109	CcSEcCtD
Arformoterol—Arthralgia—Valproic Acid—migraine	0.000224	0.00109	CcSEcCtD
Arformoterol—Chest pain—Valproic Acid—migraine	0.000224	0.00109	CcSEcCtD
Arformoterol—Haematuria—Topiramate—migraine	0.000224	0.00109	CcSEcCtD
Arformoterol—Anxiety—Valproic Acid—migraine	0.000223	0.00109	CcSEcCtD
Arformoterol—Hypersensitivity—Verapamil—migraine	0.000223	0.00109	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000222	0.00109	CcSEcCtD
Arformoterol—Discomfort—Valproic Acid—migraine	0.000221	0.00108	CcSEcCtD
Arformoterol—Sinusitis—Topiramate—migraine	0.00022	0.00108	CcSEcCtD
Arformoterol—Mental disorder—Gabapentin—migraine	0.000219	0.00107	CcSEcCtD
Arformoterol—Dry mouth—Valproic Acid—migraine	0.000219	0.00107	CcSEcCtD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000218	0.00433	CbGpPWpGaD
Arformoterol—Malnutrition—Gabapentin—migraine	0.000218	0.00107	CcSEcCtD
Arformoterol—Dizziness—Propranolol—migraine	0.000218	0.00106	CcSEcCtD
Arformoterol—Asthenia—Verapamil—migraine	0.000217	0.00106	CcSEcCtD
Arformoterol—Anaphylactic shock—Valproic Acid—migraine	0.000215	0.00105	CcSEcCtD
Arformoterol—Oedema—Valproic Acid—migraine	0.000215	0.00105	CcSEcCtD
Arformoterol—Pruritus—Verapamil—migraine	0.000214	0.00105	CcSEcCtD
Arformoterol—Tension—Gabapentin—migraine	0.000214	0.00105	CcSEcCtD
Arformoterol—Angioedema—Timolol—migraine	0.000214	0.00105	CcSEcCtD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000214	0.00424	CbGpPWpGaD
Arformoterol—Dysgeusia—Gabapentin—migraine	0.000214	0.00104	CcSEcCtD
Arformoterol—ADRB2—GPCRs, Other—HTR2A—migraine	0.000213	0.00423	CbGpPWpGaD
Arformoterol—Infection—Valproic Acid—migraine	0.000213	0.00104	CcSEcCtD
Arformoterol—CYP2A6—NRF2 pathway—SLC6A4—migraine	0.000213	0.00422	CbGpPWpGaD
Arformoterol—Nervousness—Gabapentin—migraine	0.000212	0.00103	CcSEcCtD
Arformoterol—Rhinitis—Topiramate—migraine	0.000211	0.00103	CcSEcCtD
Arformoterol—Back pain—Gabapentin—migraine	0.000211	0.00103	CcSEcCtD
Arformoterol—Nervous system disorder—Valproic Acid—migraine	0.000211	0.00103	CcSEcCtD
Arformoterol—Muscle spasms—Gabapentin—migraine	0.00021	0.00102	CcSEcCtD
Arformoterol—Tachycardia—Valproic Acid—migraine	0.000209	0.00102	CcSEcCtD
Arformoterol—Vomiting—Propranolol—migraine	0.000209	0.00102	CcSEcCtD
Arformoterol—Pharyngitis—Topiramate—migraine	0.000209	0.00102	CcSEcCtD
Arformoterol—Skin disorder—Valproic Acid—migraine	0.000208	0.00102	CcSEcCtD
Arformoterol—Urinary tract disorder—Topiramate—migraine	0.000208	0.00102	CcSEcCtD
Arformoterol—Oedema peripheral—Topiramate—migraine	0.000208	0.00101	CcSEcCtD
Arformoterol—Rash—Propranolol—migraine	0.000208	0.00101	CcSEcCtD
Arformoterol—Dermatitis—Propranolol—migraine	0.000207	0.00101	CcSEcCtD
Arformoterol—Diarrhoea—Verapamil—migraine	0.000207	0.00101	CcSEcCtD
Arformoterol—Connective tissue disorder—Topiramate—migraine	0.000207	0.00101	CcSEcCtD
Arformoterol—Palpitations—Timolol—migraine	0.000207	0.00101	CcSEcCtD
Arformoterol—Urethral disorder—Topiramate—migraine	0.000207	0.00101	CcSEcCtD
Arformoterol—Cough—Timolol—migraine	0.000204	0.000998	CcSEcCtD
Arformoterol—Tremor—Gabapentin—migraine	0.000204	0.000998	CcSEcCtD
Arformoterol—Visual impairment—Topiramate—migraine	0.000203	0.000992	CcSEcCtD
Arformoterol—Ill-defined disorder—Gabapentin—migraine	0.000202	0.000989	CcSEcCtD
Arformoterol—Hypertension—Timolol—migraine	0.000202	0.000988	CcSEcCtD
Arformoterol—Hypotension—Valproic Acid—migraine	0.000201	0.00098	CcSEcCtD
Arformoterol—Agitation—Gabapentin—migraine	0.0002	0.000979	CcSEcCtD
Arformoterol—Dizziness—Verapamil—migraine	0.0002	0.000978	CcSEcCtD
Arformoterol—Chest pain—Timolol—migraine	0.000199	0.000974	CcSEcCtD
Arformoterol—Myalgia—Timolol—migraine	0.000199	0.000974	CcSEcCtD
Arformoterol—Arthralgia—Timolol—migraine	0.000199	0.000974	CcSEcCtD
Arformoterol—Angioedema—Gabapentin—migraine	0.000199	0.000974	CcSEcCtD
Arformoterol—Anxiety—Timolol—migraine	0.000199	0.000971	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000198	0.000967	CcSEcCtD
Arformoterol—Discomfort—Timolol—migraine	0.000197	0.000962	CcSEcCtD
Arformoterol—Malaise—Gabapentin—migraine	0.000197	0.000961	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Valproic Acid—migraine	0.000196	0.000956	CcSEcCtD
Arformoterol—Cardiac disorder—Topiramate—migraine	0.000196	0.000956	CcSEcCtD
Arformoterol—Nausea—Propranolol—migraine	0.000195	0.000955	CcSEcCtD
Arformoterol—Dry mouth—Timolol—migraine	0.000195	0.000953	CcSEcCtD
Arformoterol—Insomnia—Valproic Acid—migraine	0.000194	0.000949	CcSEcCtD
Arformoterol—Palpitations—Gabapentin—migraine	0.000193	0.000942	CcSEcCtD
Arformoterol—Vomiting—Verapamil—migraine	0.000192	0.000941	CcSEcCtD
Arformoterol—Dyspnoea—Valproic Acid—migraine	0.000191	0.000935	CcSEcCtD
Arformoterol—Anaphylactic shock—Timolol—migraine	0.000191	0.000934	CcSEcCtD
Arformoterol—Oedema—Timolol—migraine	0.000191	0.000934	CcSEcCtD
Arformoterol—Rash—Verapamil—migraine	0.000191	0.000933	CcSEcCtD
Arformoterol—Somnolence—Valproic Acid—migraine	0.000191	0.000933	CcSEcCtD
Arformoterol—Dermatitis—Verapamil—migraine	0.000191	0.000932	CcSEcCtD
Arformoterol—Immune system disorder—Topiramate—migraine	0.00019	0.00093	CcSEcCtD
Arformoterol—Cough—Gabapentin—migraine	0.00019	0.00093	CcSEcCtD
Arformoterol—Mediastinal disorder—Topiramate—migraine	0.00019	0.000928	CcSEcCtD
Arformoterol—Infection—Timolol—migraine	0.00019	0.000928	CcSEcCtD
Arformoterol—Headache—Verapamil—migraine	0.00019	0.000927	CcSEcCtD
Arformoterol—Dyspepsia—Valproic Acid—migraine	0.000189	0.000923	CcSEcCtD
Arformoterol—Hypertension—Gabapentin—migraine	0.000188	0.00092	CcSEcCtD
Arformoterol—Nervous system disorder—Timolol—migraine	0.000187	0.000916	CcSEcCtD
Arformoterol—Chest pain—Gabapentin—migraine	0.000186	0.000907	CcSEcCtD
Arformoterol—Arthralgia—Gabapentin—migraine	0.000186	0.000907	CcSEcCtD
Arformoterol—Myalgia—Gabapentin—migraine	0.000186	0.000907	CcSEcCtD
Arformoterol—Skin disorder—Timolol—migraine	0.000186	0.000907	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Valproic Acid—migraine	0.000185	0.000906	CcSEcCtD
Arformoterol—Fatigue—Valproic Acid—migraine	0.000185	0.000904	CcSEcCtD
Arformoterol—Anxiety—Gabapentin—migraine	0.000185	0.000904	CcSEcCtD
Arformoterol—Mental disorder—Topiramate—migraine	0.000185	0.000902	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000184	0.000901	CcSEcCtD
Arformoterol—Pain—Valproic Acid—migraine	0.000184	0.000897	CcSEcCtD
Arformoterol—Constipation—Valproic Acid—migraine	0.000184	0.000897	CcSEcCtD
Arformoterol—Malnutrition—Topiramate—migraine	0.000183	0.000896	CcSEcCtD
Arformoterol—Discomfort—Gabapentin—migraine	0.000183	0.000896	CcSEcCtD
Arformoterol—Dry mouth—Gabapentin—migraine	0.000182	0.000887	CcSEcCtD
Arformoterol—Tension—Topiramate—migraine	0.00018	0.00088	CcSEcCtD
Arformoterol—Nausea—Verapamil—migraine	0.00018	0.000879	CcSEcCtD
Arformoterol—Dysgeusia—Topiramate—migraine	0.00018	0.000878	CcSEcCtD
Arformoterol—ADRB1—GPCR ligand binding—HTR1D—migraine	0.000179	0.00355	CbGpPWpGaD
Arformoterol—Hypotension—Timolol—migraine	0.000179	0.000873	CcSEcCtD
Arformoterol—Nervousness—Topiramate—migraine	0.000178	0.000871	CcSEcCtD
Arformoterol—Oedema—Gabapentin—migraine	0.000178	0.00087	CcSEcCtD
Arformoterol—Anaphylactic shock—Gabapentin—migraine	0.000178	0.00087	CcSEcCtD
Arformoterol—Back pain—Topiramate—migraine	0.000177	0.000867	CcSEcCtD
Arformoterol—Feeling abnormal—Valproic Acid—migraine	0.000177	0.000864	CcSEcCtD
Arformoterol—Infection—Gabapentin—migraine	0.000177	0.000864	CcSEcCtD
Arformoterol—Muscle spasms—Topiramate—migraine	0.000176	0.000862	CcSEcCtD
Arformoterol—Gastrointestinal pain—Valproic Acid—migraine	0.000176	0.000858	CcSEcCtD
Arformoterol—ADRB2—GPCR ligand binding—HTR1D—migraine	0.000175	0.00347	CbGpPWpGaD
Arformoterol—Nervous system disorder—Gabapentin—migraine	0.000175	0.000853	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Timolol—migraine	0.000174	0.000851	CcSEcCtD
Arformoterol—Tachycardia—Gabapentin—migraine	0.000174	0.000849	CcSEcCtD
Arformoterol—Skin disorder—Gabapentin—migraine	0.000173	0.000845	CcSEcCtD
Arformoterol—Insomnia—Timolol—migraine	0.000173	0.000845	CcSEcCtD
Arformoterol—Tremor—Topiramate—migraine	0.000172	0.00084	CcSEcCtD
Arformoterol—Urticaria—Valproic Acid—migraine	0.000171	0.000833	CcSEcCtD
Arformoterol—Dyspnoea—Timolol—migraine	0.00017	0.000833	CcSEcCtD
Arformoterol—Ill-defined disorder—Topiramate—migraine	0.00017	0.000832	CcSEcCtD
Arformoterol—Somnolence—Timolol—migraine	0.00017	0.00083	CcSEcCtD
Arformoterol—Abdominal pain—Valproic Acid—migraine	0.00017	0.000829	CcSEcCtD
Arformoterol—Body temperature increased—Valproic Acid—migraine	0.00017	0.000829	CcSEcCtD
Arformoterol—Agitation—Topiramate—migraine	0.000169	0.000824	CcSEcCtD
Arformoterol—Dyspepsia—Timolol—migraine	0.000168	0.000822	CcSEcCtD
Arformoterol—ADRB1—GPCR ligand binding—HTR2B—migraine	0.000166	0.0033	CbGpPWpGaD
Arformoterol—Hypotension—Gabapentin—migraine	0.000166	0.000813	CcSEcCtD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000166	0.00329	CbGpPWpGaD
Arformoterol—Malaise—Topiramate—migraine	0.000165	0.000808	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Timolol—migraine	0.000165	0.000806	CcSEcCtD
Arformoterol—Fatigue—Timolol—migraine	0.000165	0.000805	CcSEcCtD
Arformoterol—Pain—Timolol—migraine	0.000163	0.000799	CcSEcCtD
Arformoterol—ADRB2—GPCR ligand binding—HTR2B—migraine	0.000163	0.00323	CbGpPWpGaD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000163	0.00322	CbGpPWpGaD
Arformoterol—Musculoskeletal discomfort—Gabapentin—migraine	0.000162	0.000792	CcSEcCtD
Arformoterol—Palpitations—Topiramate—migraine	0.000162	0.000792	CcSEcCtD
Arformoterol—Insomnia—Gabapentin—migraine	0.000161	0.000787	CcSEcCtD
Arformoterol—CYP2A6—NRF2 pathway—TGFBR2—migraine	0.000161	0.00318	CbGpPWpGaD
Arformoterol—Cough—Topiramate—migraine	0.00016	0.000782	CcSEcCtD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00016	0.00317	CbGpPWpGaD
Arformoterol—Dyspnoea—Gabapentin—migraine	0.000159	0.000775	CcSEcCtD
Arformoterol—Hypertension—Topiramate—migraine	0.000158	0.000774	CcSEcCtD
Arformoterol—Somnolence—Gabapentin—migraine	0.000158	0.000773	CcSEcCtD
Arformoterol—Hypersensitivity—Valproic Acid—migraine	0.000158	0.000773	CcSEcCtD
Arformoterol—Feeling abnormal—Timolol—migraine	0.000157	0.00077	CcSEcCtD
Arformoterol—Dyspepsia—Gabapentin—migraine	0.000157	0.000765	CcSEcCtD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000156	0.0031	CbGpPWpGaD
Arformoterol—Gastrointestinal pain—Timolol—migraine	0.000156	0.000764	CcSEcCtD
Arformoterol—Chest pain—Topiramate—migraine	0.000156	0.000763	CcSEcCtD
Arformoterol—Arthralgia—Topiramate—migraine	0.000156	0.000763	CcSEcCtD
Arformoterol—Myalgia—Topiramate—migraine	0.000156	0.000763	CcSEcCtD
Arformoterol—Anxiety—Topiramate—migraine	0.000156	0.000761	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000155	0.000758	CcSEcCtD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000155	0.00306	CbGpPWpGaD
Arformoterol—Discomfort—Topiramate—migraine	0.000154	0.000754	CcSEcCtD
Arformoterol—Asthenia—Valproic Acid—migraine	0.000154	0.000753	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Gabapentin—migraine	0.000154	0.000751	CcSEcCtD
Arformoterol—Fatigue—Gabapentin—migraine	0.000153	0.00075	CcSEcCtD
Arformoterol—Dry mouth—Topiramate—migraine	0.000153	0.000746	CcSEcCtD
Arformoterol—Pain—Gabapentin—migraine	0.000152	0.000744	CcSEcCtD
Arformoterol—Constipation—Gabapentin—migraine	0.000152	0.000744	CcSEcCtD
Arformoterol—Pruritus—Valproic Acid—migraine	0.000152	0.000742	CcSEcCtD
Arformoterol—Urticaria—Timolol—migraine	0.000152	0.000742	CcSEcCtD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000151	0.003	CbGpPWpGaD
Arformoterol—Abdominal pain—Timolol—migraine	0.000151	0.000738	CcSEcCtD
Arformoterol—Body temperature increased—Timolol—migraine	0.000151	0.000738	CcSEcCtD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00015	0.00298	CbGpPWpGaD
Arformoterol—Oedema—Topiramate—migraine	0.00015	0.000732	CcSEcCtD
Arformoterol—Infection—Topiramate—migraine	0.000149	0.000727	CcSEcCtD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000147	0.00291	CbGpPWpGaD
Arformoterol—Diarrhoea—Valproic Acid—migraine	0.000147	0.000718	CcSEcCtD
Arformoterol—Nervous system disorder—Topiramate—migraine	0.000147	0.000717	CcSEcCtD
Arformoterol—Feeling abnormal—Gabapentin—migraine	0.000147	0.000717	CcSEcCtD
Arformoterol—Tachycardia—Topiramate—migraine	0.000146	0.000714	CcSEcCtD
Arformoterol—Gastrointestinal pain—Gabapentin—migraine	0.000146	0.000711	CcSEcCtD
Arformoterol—Skin disorder—Topiramate—migraine	0.000145	0.000711	CcSEcCtD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000142	0.00282	CbGpPWpGaD
Arformoterol—Dizziness—Valproic Acid—migraine	0.000142	0.000694	CcSEcCtD
Arformoterol—Urticaria—Gabapentin—migraine	0.000141	0.000691	CcSEcCtD
Arformoterol—Hypersensitivity—Timolol—migraine	0.000141	0.000688	CcSEcCtD
Arformoterol—Abdominal pain—Gabapentin—migraine	0.000141	0.000687	CcSEcCtD
Arformoterol—Body temperature increased—Gabapentin—migraine	0.000141	0.000687	CcSEcCtD
Arformoterol—Hypotension—Topiramate—migraine	0.00014	0.000684	CcSEcCtD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000139	0.00276	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—CALCRL—migraine	0.000139	0.00276	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—RAMP1—migraine	0.000139	0.00276	CbGpPWpGaD
Arformoterol—Asthenia—Timolol—migraine	0.000137	0.00067	CcSEcCtD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000137	0.00272	CbGpPWpGaD
Arformoterol—Vomiting—Valproic Acid—migraine	0.000136	0.000667	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Topiramate—migraine	0.000136	0.000667	CcSEcCtD
Arformoterol—ADRB2—GPCR downstream signaling—CALCRL—migraine	0.000136	0.0027	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—RAMP1—migraine	0.000136	0.0027	CbGpPWpGaD
Arformoterol—Insomnia—Topiramate—migraine	0.000135	0.000662	CcSEcCtD
Arformoterol—Rash—Valproic Acid—migraine	0.000135	0.000661	CcSEcCtD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000135	0.00268	CbGpPWpGaD
Arformoterol—Dermatitis—Valproic Acid—migraine	0.000135	0.000661	CcSEcCtD
Arformoterol—Pruritus—Timolol—migraine	0.000135	0.000661	CcSEcCtD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000135	0.00268	CbGpPWpGaD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000135	0.00268	CbGpPWpGaD
Arformoterol—Headache—Valproic Acid—migraine	0.000134	0.000657	CcSEcCtD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000134	0.00266	CbGpPWpGaD
Arformoterol—Dyspnoea—Topiramate—migraine	0.000133	0.000652	CcSEcCtD
Arformoterol—Somnolence—Topiramate—migraine	0.000133	0.00065	CcSEcCtD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000132	0.00262	CbGpPWpGaD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000132	0.00262	CbGpPWpGaD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000132	0.00262	CbGpPWpGaD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000132	0.00262	CbGpPWpGaD
Arformoterol—Dyspepsia—Topiramate—migraine	0.000132	0.000644	CcSEcCtD
Arformoterol—Hypersensitivity—Gabapentin—migraine	0.000131	0.000641	CcSEcCtD
Arformoterol—Diarrhoea—Timolol—migraine	0.000131	0.000639	CcSEcCtD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000129	0.00257	CbGpPWpGaD
Arformoterol—Gastrointestinal disorder—Topiramate—migraine	0.000129	0.000632	CcSEcCtD
Arformoterol—Fatigue—Topiramate—migraine	0.000129	0.000631	CcSEcCtD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000129	0.00255	CbGpPWpGaD
Arformoterol—Pain—Topiramate—migraine	0.000128	0.000626	CcSEcCtD
Arformoterol—Constipation—Topiramate—migraine	0.000128	0.000626	CcSEcCtD
Arformoterol—Asthenia—Gabapentin—migraine	0.000128	0.000624	CcSEcCtD
Arformoterol—Nausea—Valproic Acid—migraine	0.000128	0.000623	CcSEcCtD
Arformoterol—ADRB1—Signaling by GPCR—RAMP1—migraine	0.000126	0.00251	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CALCRL—migraine	0.000126	0.00251	CbGpPWpGaD
Arformoterol—Dizziness—Timolol—migraine	0.000126	0.000618	CcSEcCtD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000126	0.0025	CbGpPWpGaD
Arformoterol—Pruritus—Gabapentin—migraine	0.000126	0.000615	CcSEcCtD
Arformoterol—ADRB2—Signaling by GPCR—RAMP1—migraine	0.000124	0.00245	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CALCRL—migraine	0.000124	0.00245	CbGpPWpGaD
Arformoterol—Feeling abnormal—Topiramate—migraine	0.000123	0.000603	CcSEcCtD
Arformoterol—Gastrointestinal pain—Topiramate—migraine	0.000122	0.000598	CcSEcCtD
Arformoterol—Diarrhoea—Gabapentin—migraine	0.000122	0.000595	CcSEcCtD
Arformoterol—Vomiting—Timolol—migraine	0.000121	0.000594	CcSEcCtD
Arformoterol—Rash—Timolol—migraine	0.00012	0.000589	CcSEcCtD
Arformoterol—Dermatitis—Timolol—migraine	0.00012	0.000588	CcSEcCtD
Arformoterol—Headache—Timolol—migraine	0.00012	0.000585	CcSEcCtD
Arformoterol—Urticaria—Topiramate—migraine	0.000119	0.000581	CcSEcCtD
Arformoterol—Body temperature increased—Topiramate—migraine	0.000118	0.000578	CcSEcCtD
Arformoterol—Abdominal pain—Topiramate—migraine	0.000118	0.000578	CcSEcCtD
Arformoterol—Dizziness—Gabapentin—migraine	0.000118	0.000575	CcSEcCtD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000116	0.0023	CbGpPWpGaD
Arformoterol—Nausea—Timolol—migraine	0.000114	0.000555	CcSEcCtD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000113	0.00225	CbGpPWpGaD
Arformoterol—Vomiting—Gabapentin—migraine	0.000113	0.000553	CcSEcCtD
Arformoterol—Rash—Gabapentin—migraine	0.000112	0.000548	CcSEcCtD
Arformoterol—Dermatitis—Gabapentin—migraine	0.000112	0.000548	CcSEcCtD
Arformoterol—Headache—Gabapentin—migraine	0.000111	0.000545	CcSEcCtD
Arformoterol—Hypersensitivity—Topiramate—migraine	0.00011	0.000539	CcSEcCtD
Arformoterol—ADRB1—GPCR ligand binding—HTR1B—migraine	0.000108	0.00215	CbGpPWpGaD
Arformoterol—Asthenia—Topiramate—migraine	0.000107	0.000525	CcSEcCtD
Arformoterol—ADRB2—GPCR ligand binding—HTR1B—migraine	0.000106	0.0021	CbGpPWpGaD
Arformoterol—Pruritus—Topiramate—migraine	0.000106	0.000518	CcSEcCtD
Arformoterol—Nausea—Gabapentin—migraine	0.000106	0.000517	CcSEcCtD
Arformoterol—ADRB1—GPCR ligand binding—HTR1A—migraine	0.000104	0.00207	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—TAC1—migraine	0.000103	0.00204	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—NPS—migraine	0.000103	0.00204	CbGpPWpGaD
Arformoterol—Diarrhoea—Topiramate—migraine	0.000102	0.000501	CcSEcCtD
Arformoterol—ADRB2—GPCR ligand binding—HTR1A—migraine	0.000102	0.00202	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—HTR1D—migraine	0.000101	0.002	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—HTR2C—migraine	0.000101	0.002	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—NPS—migraine	0.000101	0.00199	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—TAC1—migraine	0.000101	0.00199	CbGpPWpGaD
Arformoterol—Dizziness—Topiramate—migraine	9.9e-05	0.000484	CcSEcCtD
Arformoterol—ADRB2—GPCR downstream signaling—HTR1D—migraine	9.89e-05	0.00196	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—HTR2C—migraine	9.86e-05	0.00195	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—EDNRA—migraine	9.81e-05	0.00194	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—EDNRA—migraine	9.59e-05	0.0019	CbGpPWpGaD
Arformoterol—Vomiting—Topiramate—migraine	9.52e-05	0.000465	CcSEcCtD
Arformoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9.48e-05	0.00188	CbGpPWpGaD
Arformoterol—Rash—Topiramate—migraine	9.44e-05	0.000461	CcSEcCtD
Arformoterol—ADRB1—GPCR ligand binding—CALCA—migraine	9.44e-05	0.00187	CbGpPWpGaD
Arformoterol—Dermatitis—Topiramate—migraine	9.43e-05	0.000461	CcSEcCtD
Arformoterol—ADRB1—GPCR downstream signaling—HTR2B—migraine	9.4e-05	0.00186	CbGpPWpGaD
Arformoterol—Headache—Topiramate—migraine	9.38e-05	0.000458	CcSEcCtD
Arformoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9.27e-05	0.00184	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—CALCA—migraine	9.23e-05	0.00183	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—HTR2B—migraine	9.2e-05	0.00182	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR1D—migraine	9.18e-05	0.00182	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR1D—migraine	8.98e-05	0.00178	CbGpPWpGaD
Arformoterol—Nausea—Topiramate—migraine	8.89e-05	0.000435	CcSEcCtD
Arformoterol—ADRB1—GPCR ligand binding—HTR7—migraine	8.83e-05	0.00175	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—HTR7—migraine	8.64e-05	0.00171	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR2B—migraine	8.54e-05	0.00169	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR2B—migraine	8.35e-05	0.00166	CbGpPWpGaD
Arformoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	8.12e-05	0.00161	CbGpPWpGaD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	7.94e-05	0.00157	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—RAMP1—migraine	7.47e-05	0.00148	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CALCRL—migraine	7.47e-05	0.00148	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—RAMP1—migraine	7.3e-05	0.00145	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CALCRL—migraine	7.3e-05	0.00145	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—HTR2A—migraine	6.18e-05	0.00123	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—HTR1B—migraine	6.13e-05	0.00121	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—HTR2A—migraine	6.05e-05	0.0012	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—HTR1B—migraine	5.99e-05	0.00119	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CACNA1A—migraine	5.91e-05	0.00117	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—HTR1A—migraine	5.9e-05	0.00117	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—NPS—migraine	5.81e-05	0.00115	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—TAC1—migraine	5.81e-05	0.00115	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—HTR1A—migraine	5.77e-05	0.00114	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—HTR2C—migraine	5.7e-05	0.00113	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—NPS—migraine	5.68e-05	0.00113	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—TAC1—migraine	5.68e-05	0.00113	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—HTR2C—migraine	5.57e-05	0.0011	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR1B—migraine	5.56e-05	0.0011	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—EDNRA—migraine	5.54e-05	0.0011	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR1B—migraine	5.44e-05	0.00108	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR1D—migraine	5.43e-05	0.00108	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—EDNRA—migraine	5.42e-05	0.00107	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR1A—migraine	5.36e-05	0.00106	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—CALCA—migraine	5.33e-05	0.00106	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR1D—migraine	5.31e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—TAC1—migraine	5.27e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—NPS—migraine	5.27e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR1A—migraine	5.24e-05	0.00104	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—CALCA—migraine	5.22e-05	0.00103	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR2C—migraine	5.17e-05	0.00103	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—NPS—migraine	5.16e-05	0.00102	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—TAC1—migraine	5.16e-05	0.00102	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR2C—migraine	5.06e-05	0.001	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR2B—migraine	5.04e-05	0.001	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—EDNRA—migraine	5.03e-05	0.000998	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—HTR7—migraine	4.99e-05	0.000989	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR2B—migraine	4.93e-05	0.000978	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—EDNRA—migraine	4.92e-05	0.000976	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—HTR7—migraine	4.88e-05	0.000968	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CALCA—migraine	4.84e-05	0.00096	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CALCA—migraine	4.74e-05	0.000939	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR7—migraine	4.53e-05	0.000898	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—LRP1—migraine	4.44e-05	0.00088	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR7—migraine	4.43e-05	0.000879	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—LRP1—migraine	4.34e-05	0.000861	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CACNA1A—migraine	3.6e-05	0.000715	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—HTR2A—migraine	3.49e-05	0.000693	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—HTR2A—migraine	3.42e-05	0.000678	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOTCH4—migraine	3.41e-05	0.000675	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOTCH4—migraine	3.33e-05	0.000661	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CACNA1A—migraine	3.32e-05	0.000657	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR1B—migraine	3.29e-05	0.000652	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CACNA1A—migraine	3.29e-05	0.000652	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR1B—migraine	3.22e-05	0.000637	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HTR2A—migraine	3.17e-05	0.000629	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR1A—migraine	3.16e-05	0.000627	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TAC1—migraine	3.12e-05	0.000618	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NPS—migraine	3.12e-05	0.000618	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PGR—migraine	3.12e-05	0.000618	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HTR2A—migraine	3.1e-05	0.000615	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR1A—migraine	3.1e-05	0.000614	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR2C—migraine	3.06e-05	0.000606	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PGR—migraine	3.05e-05	0.000604	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NPS—migraine	3.05e-05	0.000604	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TAC1—migraine	3.05e-05	0.000604	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR2C—migraine	2.99e-05	0.000593	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EDNRA—migraine	2.97e-05	0.000589	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EDNRA—migraine	2.91e-05	0.000576	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOTCH3—migraine	2.9e-05	0.000574	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CALCA—migraine	2.86e-05	0.000567	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOTCH3—migraine	2.83e-05	0.000562	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CALCA—migraine	2.8e-05	0.000555	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR7—migraine	2.68e-05	0.000531	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR7—migraine	2.62e-05	0.000519	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TGFBR2—migraine	2.3e-05	0.000457	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TGFBR2—migraine	2.25e-05	0.000447	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—MTHFR—migraine	1.96e-05	0.000388	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HTR2A—migraine	1.87e-05	0.000372	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HTR2A—migraine	1.83e-05	0.000364	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—ESR1—migraine	1.66e-05	0.00033	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—ESR1—migraine	1.63e-05	0.000323	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—MTHFR—migraine	1.19e-05	0.000236	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—MTHFR—migraine	1.1e-05	0.000217	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—MTHFR—migraine	1.09e-05	0.000216	CbGpPWpGaD
